Evidence map›Paper›PMID 33619495›Full record

ArticlebioRxiv : the preprint server for biology2021

HLA binding of self-peptides is biased towards proteins with specific molecular functions.

Vadim Karnaukhov, Wayne Paes, Isaac B Woodhouse, Thomas Partridge, Annalisa Nicastri, Simon Brackenridge, Dmitrii Scherbinin, Dmitry M Chudakov, Ivan V Zvyagin, Nicola Ternette and 3 more

Open access · greenAbstract readPreprint
In one paragraph

Article in bioRxiv : the preprint server for biology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 10 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 4 institutions in 2 countries.

Vadim KarnaukhovCenter of Life Sciences, Skolkovo Institute of Science and Technology, Moscow, Russia.
Wayne PaesNuffield Department of Clinical Medicine, University of Oxford, Oxford, UK.
Isaac B WoodhouseMedical Research Council (MRC) Human Immunology Unit, MRC Weatherall Institute of Molecular Medicine (WIMM), John Radcliffe Hospital, University of Oxford, Oxford, UK.
Thomas PartridgeNuffield Department of Clinical Medicine, University of Oxford, Oxford, UK.
Annalisa NicastriThe Jenner Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK.
Simon BrackenridgeNuffield Department of Clinical Medicine, University of Oxford, Oxford, UK.
Dmitrii ScherbininShemyakin-Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Science, Moscow, Russia.
Dmitry M ChudakovCenter of Life Sciences, Skolkovo Institute of Science and Technology, Moscow, Russia.
Ivan V ZvyaginShemyakin-Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Science, Moscow, Russia.
Nicola TernetteThe Jenner Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK.
Hashem KoohyMedical Research Council (MRC) Human Immunology Unit, MRC Weatherall Institute of Molecular Medicine (WIMM), John Radcliffe Hospital, University of Oxford, Oxford, UK.
Persephone BorrowNuffield Department of Clinical Medicine, University of Oxford, Oxford, UK.
Mikhail ShugayShemyakin-Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Science, Moscow, Russia.
University of Oxford · GBPirogov Russian National Research Medical University · RUJohn Radcliffe Hospital · GBSkolkovo Institute of Science and Technology · RU

Funding

Targeting 5' leader-encoded defective ribosomal products for HIV T cell vaccinesR01AI118549 · NIAID · UNIVERSITY OF PENNSYLVANIA · PI SHAW, GEORGE M · 2016 to 2020
$3.6M
Medical Research Council MR/K012037/1NIAID NIH HHS R01 AI118549
6 · The paper itself

Abstract

Human leukocyte antigen (HLA) is highly polymorphic and plays a key role in guiding adaptive immune responses by presenting foreign and self peptides to T cells. Each HLA variant selects a minor fraction of peptides that match a certain motif required for optimal interaction with the peptide-binding groove. These restriction rules define the landscape of peptides presented to T cells. Given these limitations, one might suggest that the choice of peptides presented by HLA is non-random and there is preferential presentation of an array of peptides that is optimal for distinguishing self and foreign proteins. In this study we explore these preferences with a comparative analysis of self peptides enriched and depleted in HLA ligands. We show that HLAs exhibit preferences towards presenting peptides from certain proteins while disfavoring others with specific functions, and highlight differences between various HLA genes and alleles in those preferences. We link those differences to HLA anchor residue propensities and amino acid composition of preferentially presented proteins. The set of proteins that peptides presented by a given HLA are most likely to be derived from can be used to distinguish between class I and class II HLAs and HLA alleles. Our observations can be extrapolated to explain the protective effect of certain HLA alleles in infectious diseases, and we hypothesize that they can also explain susceptibility to certain autoimmune diseases and cancers. We demonstrate that these differences lead to differential presentation of HIV, influenza virus, SARS-CoV-1 and SARS-CoV-2 proteins by various HLA alleles. Finally, we show that the reported self peptidome preferences of distinct HLA variants can be compensated by combinations of HLA-A/HLA-B and HLA-A/HLA-C alleles in frequent haplotypes.

Identifiers

PMID33619495
PMCPMC7899460
OpenAlexW3131238774

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.